Givosiran
Full Prescribing Information for GIVLAARI® (givosiran)
Click below to learn more about the use of givosiran in adult patients with acute hepatic porphyria (AHP).
If you require any further information on givosiran, please connect with us by reaching out to your local Medical Science Liaison or contacting our Medical Information team.
More Information
For more information about data regarding givosiran, please visit our Congresses and Publications resource page.
Image
Long-term Assessment of Patients with AHP and AIP who were Not Attack-Free after 6-Months of Givosiran Treatment: A Post Hoc Subgroup Analysis of the Phase 3 ENVISION Study
An infographic depicting a post-hoc analysis of the ENVISION phase 3 study to understand the long-term clinical outcomes of patients who were not attack free after 6-months of givosiran treatment.
